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Abstract
Extracellular signal-regulated kinase (ERK1/2) has been implicated in modulating drug seeking
behavior and is a target of alcohol and other drugs of abuse. Given that the discriminative stimulus
(subjective/interoceptive) effects of drugs are determinants of abuse liability and can influence
drug seeking behavior, we examined the role of ERK1/2 in modulating the discriminative stimulus
effects of alcohol. Using drug discrimination procedures, rats were trained to discriminate a
moderate intragastric (IG) alcohol dose (1 g/kg) versus water (IG). Following an alcohol (1 g/kg)
discrimination session phosphorylated ERK1/2 (pERK1/2) immunoreactivity (IR) was significantly
elevated in the amygdala, but not the nucleus accumbens. Therefore, we hypothesized that intra-
amygdala inhibition of ERK1/2 would disrupt expression of the discriminative stimulus effects of
alcohol. However, intra-amygdala or accumbens administration of the MEK/ERK1/2 inhibitor
U0126 (1 and 3 μg) had no effect on the discriminative stimulus effects of the training dose of
alcohol (1 g/kg). Contrary to our hypothesis, intra-amygdala infusion of U0126 (3 μg) potentiated
the discriminative stimulus effects of a low alcohol dose (0.5 g/kg) and had no effect following
nucleus accumbens infusion. Importantly, site-specific inhibition of pERK1/2 in each brain region
was confirmed. Therefore, the increase in pERK1/2 IR in the amygdala following systemic alcohol
administration may be reflective of the widespread effects of alcohol on the brain (activation/
inhibition of brain circuits), whereas the site specific microinjection studies confirmed functional
involvement of intra-amygdala ERK1/2. These findings show that activity of the ERK signaling
pathway in the amygdala can influence the discriminative stimulus effects of alcohol.
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1. Introduction
Alcohol drinking can be impacted by a variety of factors. A likely contributor to alcohol
drinking and seeking behaviors is the interoceptive or subjective drug effects, such as the
feeling of “drunkenness” or “lightheadedness” that accompanies alcohol consumption. In
both clinical and preclinical studies, these interoceptive effects can serve as discriminative
stimuli, such that the subject uses these cues to distinguish between drug and non-drug
conditions. These interoceptive drug effects provide drug-specific feedback to the organism
and can promote drug seeking behavior [1, 2]. Therefore, examination of the neural
mechanisms that regulate these cues is critical to better understand how drugs gain control
over behavioral processes in addiction. Although the contribution of neurotransmitter
receptor systems (e.g., γ-aminobutyric acid (GABA) and N-Methyl-D-aspartic acid
(NMDA)) have been well-characterized [3, 4], the potential cell signaling mechanisms that
might underlie the expression of the discriminative stimulus (interoceptive) effects of
alcohol have not been characterized.
There is growing interest in the extracellular signal-regulated kinase (ERK) as a molecular
mechanism of drug seeking and taking behavior [5–10]. ERK is a member of the mitogen-
activated protein kinase (MAPK) family. Activation of two closely related isoforms of ERK
(ERK1 and ERK2, or ERK1/2), via phosphorylation by the upstream kinase MEK1/2, can
result in changes in gene transcription, and consequently induce long-term changes in neural
and behavioral functions [11–16]. Accordingly, there is a growing literature demonstrating
involvement of this pathway in neural plasticity and learning and memory processes [17,
18]. Further, ERK1/2 is activated in vivo by acute administration of several drugs of abuse,
including alcohol [19–24]. Interestingly, these studies show drug-induced ERK1/2 activation
in limbic brain regions known to modulate the discriminative stimulus effects of alcohol,
such as the nucleus accumbens and the amygdala [25–30]. However, it is unknown if ERK/
MAPK signaling in these key limbic structures influences the discriminative stimulus effects
of alcohol.
Accordingly, the purpose of this study was to examine the potential role of ERK/MAPK
signaling in modulating the discriminative stimulus effects of alcohol. In male rats trained to
discriminate between a moderate dose of alcohol (1 g/kg, IG) vs. water in a two-lever
discrimination task, we first examined brain regional response to alcohol as indexed by
phosphorylated (i.e., activated) ERK1/2 (pERK1/2) immunoreactivity. We focused on the
nucleus accumbens and amygdala given their known roles in regulating the discriminative
stimulus effects of alcohol. We hypothesized that in the brain region(s) that showed
sensitivity to alcohol (as measured by changes in pERK1/2 IR), ERK1/2 activity may
functionally modulate the discriminative stimulus effects of alcohol. To address this
hypothesis, discrimination trained rats were implanted with bilateral cannulae aimed at the
amygdala and nucleus accumbens for site-specific administration of the MEK/ERK1/2
inhibitor 1,4-Diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126) to assess
the functional role of ERK1/2 activity in these regions in modulating the expression of the
discriminative stimulus effects of alcohol.
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2. Materials and Methods
2.1. Animals
Male Long Evans rats (Harlan Sprague Dawley, Indianapolis, IN) were individually housed
in Plexiglas cages. Rats were handled and weighed daily for one week before lever press
training began. Rats were fed approximately 16 g of food daily for the duration of the study
such that weights were maintained at approximately 330–340 g. Water was available
continuously in the home cage. The colony room was maintained on a 12-h light/dark cycle
and experiments were conducted during the light portion of the cycle. Animals were under
continuous care and monitoring by veterinary staff from the Division of Laboratory Animal
Medicine (DLAM) at UNC-Chapel Hill. All procedures were also carried out in accordance
with the NIH Guide for the Care and Use of Laboratory Animals and institutional
guidelines.
2.2. Alcohol Discrimination Training and Testing Procedures
Discrimination training—Rats were trained on a two-lever alcohol discrimination task.
The same training procedures and conditioning chambers described in [26, 29, 31, 32] were
used. Briefly, immediately following intragastic gavage (IG) administration alcohol (1 g/kg)
or water rats were placed in the chambers and after a 10 min delay the house light was
illuminated and both levers were extended into the chamber (beginning of the 15-min
session). IG administration of alcohol results in rapid brain alcohol concentrations [33], and
the 10 min time point corresponds to the ascending limb of peak blood and brain alcohol
concentrations [33, 34]. Following alcohol administration, completion of an FR10 on the
alcohol-appropriate lever resulted in the availability of the sucrose (10%, w/v) solution.
Similarly, following water administration, completion of an FR10 on the water-appropriate
lever resulted in sucrose delivery. During both alcohol and water sessions, responses on the
inappropriate lever were recorded but produced no programmed consequences. Prior to the
start of two-lever discrimination training, rats experienced 16 errorless learning sessions, in
which only the appropriate lever (i.e., right or left) was present for the alcohol or water
session. Water and alcohol training days varied on a double alternation schedule (W, W, A,
A, …). Training sessions continued until the percentage of alcohol- and water-appropriate
lever press responses emitted prior to the first reinforcer, and during the entire session was
>80% for 8 out of 10 consecutive days. Once these criteria were met, testing began.
Confirming discriminative stimulus control by alcohol—In both experiments, once
the training criteria were met (60.1±4.1 two-lever discrimination training sessions),
discriminative stimulus control by alcohol was verified by conducting a cumulative alcohol
dose (0 – 1.7 g/kg, IG) substitution curve [26, 29, 30, 35]. Test sessions were similar to
training sessions except that they were 2 min in duration (after the 10 min delay). During
test sessions, completion of an FR10 on either lever resulted in sucrose reinforcement
delivery to assess the possible effects of treatments on overall response rate. For Experiment
2 (Section 2.4), these test sessions were interspersed with training sessions only if
performance during 3 out of the previous 4 training sessions met the accuracy criteria and
testing occurred no more than twice per week.
2.3. Experiment 1
Identification of amygdala and nucleus accumbens response to alcohol as
indexed by pERK1/2 IR—Discrimination-trained rats were administered water or alcohol
(1 g/kg, IG; n=6/group) and placed in the chambers for a standard test session. Upon
completion of the session, rats were returned to the homecage. Approximately 90 min after
the water/alcohol administration, rats were deeply anesthetized with pentobarbital and
perfused with 0.1 M PBS, followed by 4% paraformaldehyde, 4°C; pH=7.4. The brains were
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removed from the skull and placed in the same fixative solution for approximately 24 h
before being washed with PBS and sliced coronally on a vibratome into 40 μm sections.
Tissue was stored (−20°C) in cryoprotectant until immunohistochemistry processing.
pERK1/2 immunohistochemistry (IHC)—Free-floating sections were blocked in PBS/
0.1% Triton-X/10% goat serum, and then incubated in PBS/0.1% Triton X/3% goat serum,
and rabbit anti-phospho-p44/42 MAP kinase (1:400; Cell Signaling Technology, Inc., MA)
for 16 h, at 4° C with agitation. Sections were then incubated in secondary antibody for 1 h
using the Dako EnVision Kit (Dako, Carpinteria, CA). Immunoreactivity was detected with
nickel-enhanced diaminobenzidine (Dako EnVision Kit) as a chromagen. Sections were then
counterstained with toluidine blue (0.012%), mounted, dried and coverslipped. For
consistency of staining across subjects, the brain tissue from each experiment was processed
simultaneously.
pERK1/2 immunohistochemical quantification—Immunoreactivity (IR) was
quantified as described in [5, 26, 29, 36]. Briefly, pERK1/2 IR (i.e., pixel density/mm2;
optical density) was visualized using an Olympus CX41 light microscope (Olympus
America, Center Valley, PA) and image analysis software (Bioquant Nova Advanced Image
Analysis; R&M Biometric, Nashville, TN). The microscope, camera, and software were
background corrected and normalized to preset light levels to ensure fidelity of data
acquisition. Analysis was conducted by a researcher blind to treatment conditions. Data
were acquired from a minimum of two sections/brain region/animal and the data were
averaged to obtain a single value per subject. The brain regions examined were the nucleus
accumbens (shell and core; AP +1.7 to 1.0 mm) and the amygdala (central nucleus - CeA,
basolateral - BLA, dorsolateral - LaDL; AP −1.8 to −2.5).
2.4. Experiment 2
Effects of intra-amygdala and intra-accumbens ERK1/2 inhibition on the
discriminative stimulus effects of alcohol—To determine the functional involvement
of ERK1/2 activity on the discriminative stimulus effects of alcohol (1 g/kg, IG),
discrimination-trained rats (n=11) were implanted with bilateral guide cannulae (26-gauge;
Plastics One, VA) that terminated 2 mm above the amygdala (CeA) and the nucleus
accumbens (core), as described in detail in [26, 29]. The coordinates (in mm) for the
amygdala and nucleus accumbens were AP −1.9, ML +4.2, DV −6.5 and AP +1.7, ML +1.5,
DV −5.5 (DV measurements from skull), respectively [37].
Site specific bilateral microinjections were made with 1.0 μl Hamilton syringes connected to
33-gauge injectors (Plastics One, VA) extending 2 mm below the guide cannulae. The
infusions were delivered by a pump (Harvard Apparatus, MA) at a volume of 0.5 μl/side
across 1 min. The injector remained in place for 1.5 min after the infusion to allow for
diffusion. The MEK/ERK1/2 inhibitor U0126 was microinfused into the amygdala (0, 1, 3
μg/0.5 μl/side) or the nucleus accumbens (0, 1, 3 μg/0.5 μl/side). After the 1.5 min diffusion
period, rats were placed in the home cage for 30 min. This 30 min pretreatment interval was
chosen based on previous work showing decreased phosphorylated ERK1/2 protein utilizing
similar infusion parameters [8, 9]. After the pretreatment interval, rats received the alcohol
training dose (1 g/kg, IG), and were placed in the chamber for a test session. For the first
tests, rats received a sham injection and a vehicle injection in the nucleus accumbens and the
same order in the amygdala. Then, in order to determine if ERK1/2 activity is required for
alcohol discrimination, U0126 (0, 1 or 3 μg) was administered in the amygdala or nucleus
accumbens in randomized order 30 min prior to systemic administration of the alcohol
training dose (1.0 g/kg, IG). Next, the ability of MEK/ERK inhibition to modulate the
discriminative stimulus effects of a lower dose of alcohol (0.5 g/kg, IG) was assessed.
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U0126 (0 or 3 μg/0.5μl/side) was microinfused into the amygdala or nucleus accumbens 30
min before alcohol (0.5 g/kg, IG) administration. Finally, to determine whether MEK/
ERK1/2 inhibition produces alcohol-like discriminative stimulus effects, U0126 (sham and 3
μg/0.5μl/side) was tested alone as described in both brain regions; however, water was
administered before the test session. For this final assessment, rats received a sham infusion
in each region in place of vehicle (aCSF/DMSO) to minimize the number of infusions, given
that a confirmational terminal infusion would be required.
Effects of U0126 on pERK1/2 IR—To confirm that the microinjection procedures
decreased ERK1/2 phosphorylation, approximately 2 weeks following the final test, rats
were divided into two groups, such that U0126 was tested in one group in the amygdala
(n=5) and in the nucleus accumbens for the other group (n=6). Rats in both groups, received
a unilateral microinjection of aCSF/DMSO vehicle on one side (e.g., left) and U0126 (3 μg)
on the other side (e.g., right). 30 min later rats were perfused, brain tissue was processed for
pERK1/2 IR and quantified as described in Experiment 1 (Section 2.3). Tissue was also
stained with cresyl violet to confirm cannulae placements. Only the data from rats with
cannulae determined to be in the target brain regions were used in the analyses.
2.5. Drugs
For intragastric gavage (IG) administration, alcohol (95% w/v) was diluted in distilled water
to a concentration of 20% (v/v) and administered in various volumes to obtain cumulative
doses of 0.1, 0.3, 1.0, and 1.7 g/kg (for the initial cumulative substitution curve). A
corresponding volume of water to the 1 g/kg alcohol training dose was used for water IG
administration. The 1 g/kg training dose was selected given that it is a moderate alcohol
dose that has been widely studied, is detectable by the animals given that it can serve as a
discriminative stimulus, and does not produce motor deficits. 1,4-Diamino-2,3-dicyano-1,4-
bis[2-aminophenylthio]butadiene (U0126), a specific inhibitor of MEK, an upstream
regulator of ERK1/2 activity [38, 39], was dissolved in 50% DMSO/artificial cerebrospinal
fluid (aCSF; in mM, 147 NaCl, 1.3 anhydrous CaCl2, 0.9 anhydrous MgCl2, 4.0 KCl;
pH=7.0–7.2) vehicle. The dose range of U0126 and the strategy of testing the same ranges in
each brain region was based on previous reports [40–44] and on pilot experiments
performed in our laboratory.
2.6. Data Analyses
Response accuracy was expressed as the percentage of alcohol-appropriate lever presses
upon delivery of the first reinforcer. Response rate (responses/min) was analyzed for the
entire session and provided an index of locomotor ability. Complete expression of the
discriminative stimulus effects of alcohol (i.e., full substitution) was defined as >80% choice
of the alcohol lever upon completion of the first FR10 during test sessions. One-way
repeated measures analysis of variance (RM ANOVA) were used to analyze response
accuracy and response rate data, with Student-Newman-Keuls post hoc analyses. Paired or
unpaired t-tests were used for two group comparisons. Statistical significance was declared
at P≤0.05.
3. Results
3.1. Confirmation of discriminative stimulus control by alcohol
After training criteria were met, alcohol discriminative stimulus control was evaluated in
each rat tested in Experiments 1 and 2, by determining a cumulative alcohol substitution
curve (Figure 1). Analyses are representative of all rats used in this study (n=23). A one-way
RM ANOVA confirmed that alcohol-appropriate responding increased as a function of
alcohol test dose [F(3,66)=43.9, p<0.001], with 1.7 g/kg resulting in full substitution (>80%)
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for the alcohol training dose (i.e., produced discriminative stimulus effects similar to the
training dose; Figure 1A). The training dose (1.0 g/kg), which generally produces >90%
alcohol-appropriate responding during regular training sessions tends to produce
approximately 60% alcohol-appropriate responding during cumulative dosing procedures
[26, 29, 30]. A significant decrease in response rate was observed at the highest alcohol dose
(1.7 g/kg; F(3,66)=10.4, p<0.001; Figure 1B). These results demonstrate dose-dependent
discriminative stimulus control by alcohol.
3.2. Experiment 1
Identification of amygdala and nucleus accumbens response to alcohol as
indexed by pERK1/2 IR—On the terminal test session, rats in both the Water and Alcohol
groups demonstrated accurate performance as demonstrated by low alcohol-appropriate
responding after water (IG) administration and high alcohol-appropriate responding after
alcohol (IG) administration (Figure 2A, left panel). Response rates did not differ between
the groups (Figure 2A, right panel).
Analysis of pERK1/2 IR in the amygdala subnuclei (CeA, BLA, LaDL) showed a significant
increase in pERK1/2 IR following alcohol (1 g/kg) administration (ps<0.05; Figure 2B, C).
No alcohol-induced differences were detected in the nucleus accumbens (core, shell).
3.3. Experiment 2
Effects of intra-amygdala and intra-accumbens ERK1/2 inhibition on the
discriminative stimulus effects of alcohol—Baseline accuracy performance (mean
±S.E.M.) from the alcohol and water session preceding the start of testing was 91.4±3.3 and
14.2±5.8% alcohol-appropriate responses, respectively. The corresponding response rates
(mean±S.E.M.) for the alcohol and water session were 59.2±3.5 and 63.8±3.0 responses/
min.
First, we sought to determine if inhibition of ERK1/2 phosphorylation would alter the
discriminative stimulus effects of the training dose of alcohol. Administration of the MEK/
ERK1/2 inhibitor U0126 (0 – 3 μg) in the amygdala (Figure 3A) or the nucleus accumbens
(Figure 3D) did not alter the discriminative stimulus effects of alcohol (1 g/kg, IG).
Response rate was not altered by intra-amygdala U0126 administration (Figure 3B), but a
significant reduction was observed following U0126 administration in the nucleus
accumbens [RM ANOVA; F(2,16)=4.18, p=0.04], with both doses reducing response rate
relative to vehicle administration (ps<0.04; Figure 3E). For each brain region, there was one
rat with a clogged cannula such that drug testing could not occur, and one with incorrect
cannulae placement (resulting in n=9/brain region; and n=4 for the amygdala group and n=5
for the nucleus accumbens group for the terminal U0126 test).
Given the lack of effect of U0126 on modulating the discriminative stimulus effects of the
alcohol training dose (1 g/kg), which could reflect a drug or behavioral ceiling effect, we
next sought to determine if U0126 infusion might alter the discriminative stimulus effects of
a lower alcohol dose (0.5 g/kg, IG; e.g., able to detect bidirectional effects). In the
amygdala, U0126 (3 μg) pretreatment significantly increased the percent of alcohol-
appropriate responding [paired t-test; t(8)=3.84, p=0.004], and did not alter response rate
(Figure 4A), indicating potentiation of the discriminative stimulus effects of the low alcohol
dose. In contrast, intra-accumbens U0126 administration did not alter alcohol-appropriate
responding, but produced a significant reduction in response rate [Figure 4B; paired t-test;
t(8)=2.75, p=0.03].
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To determine whether U0126 produced alcohol-like effects alone, the inhibitor was
administered before water. Intra-amygdala and accumbens administration of U0126 did not
produce alcohol-like discriminative stimulus effects, as evidenced by low alcohol-
appropriate responding (Figure 4C, 4D). Differential sensitivity to the motor impairing
effects of U0126 was again noted, as U0126 significantly reduced response rate in the
accumbens [paired t-test: t(8)=2.52, p=0.04], but not the amygdala (Figure 4C, 4D).
Effects of U0126 on pERK1/2 IR—Intra-amygdala U0126 administration significantly
decreased ERK1/2 activity as measured by pERK1/2 IR. The reduction was specific to the
CeA (Figure 5A; paired t-test: t(3)=3.86, p=0.03), as no change in pERK1/2 IR was evident
in the BLA (Veh: 12,328.6±2,515.1 pERK1/2 positive IR/mm2; U0126: 13,119.6±4,942.1
pERK1/2 positive IR/mm2) or LaDL (Veh: 13,775.1±2344.4 pERK1/2 positive IR/mm2;
U0126: 20,677.7±5,903.8 pERK1/2 positive IR/mm2). This confirms the function of MEK/
ERK1/2 inhibitor and the CeA-specific inhibition is consistent with previous findings in
which microinjections were targeted at the CeA [9]. Intra-accumbens administration of
U0126 showed a similar decrease in pERK1/2 in the nucleus accumbens core (Figure 5B;
paired t-test: t(4)=3.79, p=0.02), but not the shell (Veh: 41,430.6±8,400.7; U0126:
40,140.7±9,375.9). These data confirm that U0126 effectively inhibited ERK1/2 activity in
both target brain regions.
4. Discussion
In the present study, alcohol administration induced a significant increase in phosphorylated
ERK1/2 (pERK1/2) IR in subregions of the amygdala, but not the nucleus accumbens, in
alcohol discrimination-trained rats. Based on these results, we hypothesized that site specific
inhibition of ERK1/2 in the amygdala would disrupt the expression of the discriminative
stimulus effects of alcohol; however, contrary to our hypothesis MEK/ERK1/2 inhibition in
the amygdala or the nucleus accumbens did not alter the expression of the discriminative
stimulus effects of the alcohol training dose (1 g/kg). In fact, intra-amygdala ERK1/2
inhibition potentiated the discriminative stimulus effects of a low alcohol dose (0.5 g/kg); no
change following intra-accumbens administration was observed. Differential sensitivity to
ERK1/2 inhibition was also evidenced by significant reductions in response rate following
U0126 administration in the nucleus accumbens, but not the amygdala.
The differential brain regional sensitivity to MEK/ERK1/2 inhibition in relation to the
modulation of alcohol discrimination is consistent with the IHC results in which the
amygdala, but not the nucleus accumbens showed a response to alcohol as measured by
increased pERK1/2 IR. This alcohol-induced ERK1/2 activation is consistent with other work
in which alcohol administration and other drugs of abuse, have been shown to induce
phosphorylation of ERK1/2 in the central amygdala [19–24]. The increase in pERK1/2 IR in
the central amygdala following alcohol (1 g/kg, IG) administration is most in line with a
study by Ibba et al. (2009) that showed an increase in pERK1/2 in this nucleus using the
same alcohol dose and route of administration (1 g/kg, IG). Under another route of
administration, Pandey et al. (2008) report a similar alcohol (1 g/kg, IP)-induced increase in
ERK1/2 phosphorylation following an anxiety assessment (elevated plus-maze). The
similarity between the findings of the present work and these other studies is interesting
given marked differences in the experimental protocols, and suggests the generality of the
effect. For example, in the present study, rats received intermittent (double alternation
schedule) exposure to alcohol (1 g/kg, IG) during the extensive behavioral training required
by drug discrimination methods; whereas, in the Ibba et al. (2009) and Pandey et al. (2008)
studies, the alcohol-induced increase in pERK1/2 was observed following a single exposure
to alcohol in alcohol naïve animals. This may suggest that pERK1/2 response to alcohol in
the central amygdala is not altered by a history of alcohol exposure; however, continuous
Besheer et al. Page 7













exposure to alcohol (i.e., alcohol vapor exposure) has been shown to decrease pERK1/2
levels in the central amygdala [45]. Another major difference between the studies is the
timing of the alcohol injection. In the present study, the alcohol-induced increase in
pERK1/2 was evident 90 min following alcohol administration compared to 15 min [20] and
approximately 1 h [21], which could suggest an enduring alcohol-induced change. Also, in
the present study, pERK1/2 IR was compared between discrimination-trained rats
administered water or alcohol prior to the 2 min behavioral test, not to a naïve group.
Therefore, it is possible that exposure to and/or performance in the discrimination task alone
activated ERK1/2 expression in the central amygdala, and that alcohol-administration further
potentiated that level. This is plausible given that the MAPK pathway is critically involved
in learning and memory-associated plasticity processes [13, 17], and that the ERK pathway
specifically in the amygdala has been shown to regulate memory consolidation [46] and the
expression of drug-related cue learning [8, 9, 47]. Indeed, rats trained with the -opioid
receptor agonist (U-50,488H) as a discriminative stimulus have greater pERK1/2 levels in
the central amygdala relative to drug-matched controls (i.e., nondiscrimination-trained) [48],
suggestive of a learning-induced adaptation in pERK1/2. However, there is evidence to
suggest that the ERK pathway is not involved in modulating alcohol-related associative
learning (as measured by alcohol-induced conditioned place preference) [49]. It will be of
interest to directly assess the possibility of a discrimination learning-induced activation of
pERK1/2 and to examine total ERK1/2 expression in future work using both a drug-matched
control group and a drug-naïve group [50].
In the present work, pERK1/2 IR in the nucleus accumbens (core and shell) was not altered
following alcohol (1 g/kg, IG) administration. This is in contrast to results by Ibba et al.
(2009) in which pERK1/2 IR was increased in both the nucleus accumbens core and shell
following alcohol administration (0.5, 1, 2 g/kg, IG). In addition to the procedural
differences in the studies (discussed above) which could potentially account for the findings,
it is also possible that alcohol-induced pERK1/2 activation has a shorter time course and thus
was missed in the present work. That is, in the present work, brains were collected
approximately 90 min after alcohol administration vs. 15 min in the Ibba et al. (2009) study.
Importantly, the absence of an alcohol-induced change in pERK1/2 IR in the nucleus
accumbens supports the behavioral data showing lack of a functional role of accumbens
ERK1/2 in modulating the discriminative stimulus effects of alcohol.
In general, systemically and intra-amygdala and accumbens administered compounds that
reduce excitatory neurotransmission, such as GABAA agonists or NMDA antagonists tend
to substitute for alcohol (i.e., produce alcohol-like effects) or potentiate the effects of
alcohol (i.e., effects are more alcohol-like) in discrimination tasks [3, 25, 27, 28, 51–58].
Therefore, the finding that intra-amygdala U0126 administration (3 μg) potentiated effects
of the low alcohol dose (0.5 g/kg, IG) raises the possibility that inhibition of MEK/ERK1/2
activity specifically in this brain region may have contributed to decreased neuronal
excitability. Indeed, ERK1/2 inhibition in the central amygdala has been shown to decrease
neuronal excitability induced by reactive phosphorylation oxygen species [59]. Further,
while U0126 (3 μg) significantly inhibited ERK1/2 phosphorylation in the CeA (Figure 5A),
this dose administered alone was not sufficient to produce alcohol-like discriminative
stimulus effects. It will be of interest for future work to assess whether higher doses of
U0126 administered alone would induce alcohol-like effects or whether the presence of
alcohol/interaction with alcohol (as shown in the present work) is necessary for the
potentiation of the discriminative stimulus effects of alcohol.
Interestingly, while intra-accumbens U0126 decreased ERK1/2 phosphorylation in that
region (Fig 5B), MEK/ERK1/2 inhibition did not alter the expression of the discriminative
stimulus effects of the low alcohol dose (0.5 g/kg, IG) or the alcohol training dose (1 g/kg,
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IG). This pattern of results suggests a dissociation between the functional role of ERK1/2 in
the amygdala and the nucleus accumbens in the modulation of the discriminative stimulus
effects of alcohol. Further, intra-accumbens U0126 pretreatment before alcohol (1 and 0.5 g/
kg) and water, resulted in response rate reductions, which confirm that the compound was
behaviorally active following accumbens infusion, and provides further evidence of
differential sensitivity between the two brain regions given that intra-amygdala U0126 did
not alter response rates at any dose tested. Higher doses of U0126 were not tested in the
nucleus accumbens given that response rates were reduced by the highest dose tested (3 μg);
however, it is plausible that a higher dose of the MEK/ERK1/2 inhibitor could potentiate the
discriminative stimulus effects of the low alcohol dose, at a dose that induces a response rate
reduction. Regardless, this pattern of results would be consistent with the findings of the
present work, showing differential sensitivity to ERK1/2 inhibition.
An interesting observation is that under vehicle conditions pERK1/2 positive IR in the
central amygdala were approximately 10-fold higher (Experiment 2; Figure 5A) than the
nucleus accumbens core. This difference in pERK1/2 IR was not observed in Experiment 1
where the two regions showed fairly similar pERK1/2 IR following Water administration
(Figure 2B), which is consistent with previous work showing similar pERK1/2 levels
between the CeA and nucleus accumbens following saline injection [23]. While it is difficult
to compare the immunohistochemistry results across experiments given the different
procedural experience prior to sacrifice (i.e., water discrimination session vs. vehicle
microinjection), pERK1/2 IR in the nucleus accumbens following vehicle infusion is
surprisingly similar to Experiment 1 (suggesting the lack of a vehicle effect), as is pERK1/2
IR in the BLA and LaDL across the two experiments. Therefore, this data pattern suggests
that the microinjection protocol may have led to an activation of pERK1/2 in the CeA, which
would be in line with previous work showing activation of ERK1/2 in this region following
stress exposure [60].
The alcohol-induced increase in pERK1/2 IR in the amygdala led to the hypothesis that the
expression of the discriminative stimulus effects of alcohol (1 g/kg) are associated, in part,
with increased ERK1/2 phosphorylation in this region. However, inhibition of ERK1/2
activation in the amygdala by U0126, potentiated the discriminative stimulus effects of
alcohol, which was contrary to this hypothesis. A possible explanation for this apparent
discrepancy is that systemically administered alcohol can have widespread effects such that
multiple brain circuits can be activated/inhibited which could impact phosphorylation of
ERK1/2 in the central amygdala (and other regions). Overall, while this initial experiment
identified the amygdala as a region that shows a response in ERK1/2 phosphorylation
following an alcohol discrimination session, the site specific microinjection studies were
able to confirm the functional involvement of ERK1/2 in the amygdala on the discriminative
stimulus effects of alcohol.
In summary, the present findings show that the expression of the discriminative stimulus
effects of alcohol is regulated, in part, by inhibition of the phosphorylation of ERK1/2 in the
CeA. Given that interoceptive or discriminative stimulus drug cues have the potential to
impact drug seeking and taking behavior, it is possible that changes to the interoceptive
effects of consumed alcohol, as evident after ERK inhibition, may impact alcohol drinking.
Indeed, future work will be necessary to pursue this possibility; however, the novel findings
of this work show that activity of the ERK signaling pathway in the amygdala can influence
the expression of the interoceptive/discriminative stimulus effects of alcohol.
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Discrimination-trained rats show alcohol (A)-induced pERK1/2 in the amygdala
Intra-amygdala ERK inhibition potentiates low dose A discriminative stimulus (DS)
No change to A training dose DS after intra-amygdala or accumbens ERK inhibition
pERK1/2 specifically reduced after brain injection of ERK inhibitor
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Figure 1. Confirmation of discriminative stimulus control by alcohol
(A) Before testing, discriminative stimulus control was confirmed in all rats by testing a
cumulative alcohol substitution curve (n=23). Dose-dependent substitution for the 1 g/kg
alcohol dose was observed, demonstrating that the training procedures established reliable
stimulus control. (B) Response rate was reduced by the highest alcohol dose (1.7 g/kg).
Horizontal dashed lines (>80%) denote full substitution for the discriminative stimulus
effects of alcohol. Graphed values are expressed as mean ± s.e.m. *p<0.05 vs. 0.1 g/kg
alcohol (Student Newman Keuls post hoc).
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Figure 2. Alcohol administration increases pERK1/2 IR in specific nuclei of the amygdala
(A) Robust discrimination performance and similar response rates on the final test session
for rats administered water or the alcohol training dose (1 g/kg; n=6/group). Horizontal
dashed lines (>80%) denote full substitution for the discriminative stimulus effects of
alcohol. (B) Animals were sacrificed approximately 90 min following alcohol/water
administration. Significant elevations in pERK1/2 positive IR were observed in the subnuclei
of the amygdala (CeA, BLA, and LaDL) in the alcohol group relative to the Water group. In
contrast, no changes in pERK1/2 IR were observed in the nucleus accumbens core or shell.
(C) Representative photomicrographs (20X) of pERK1/2 IR in the CeA (central portion of
the CeA shown in photomicrograph) and (D) nucleus accumbens core (medial to the anterior
commissure shown in photomicrograph) after water and alcohol (1 g/kg, IG) administration.
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Scale bars, 100 μm. Graphed values are expressed as mean ± s.e.m. *p<0.05 vs. water (t-
test).
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Figure 3. MEK/ERK1/2 inhibition in the amygdala or nucleus accumbens does not alter the
discriminative stimulus effects of alcohol (1 g/kg, IG)
(A) Intra-amygdala infusion of the MEK/ERK1/2 inhibitor U0126 (n=9) 30 min prior to
alcohol (1 g/kg, IG) did not alter the discriminative stimulus effects of alcohol or (B)
response rate. (C) Illustration depicting accurate amygdala injector placements aimed at the
CeA and a corresponding photomicrograph showing an injector tract (arrow). (D) Intra-
accumbens infusion of U0126 (n=9) also did not alter the discriminative stimulus effects of
alcohol, but (E) produced significant response rate reductions. (F) Illustration depicting
accurate nucleus accumbens injector placements aimed at the core and a corresponding
photomicrograph showing an injector tract (arrow). Horizontal dashed lines (>80%) denote
full substitution for the discriminative stimulus effects of alcohol. Graphed values are
expressed as mean ± s.e.m. *p<0.05 vs. vehicle (Student Newman Keuls post hoc).
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Figure 4. Intra-amygdala MEK/ERK1/2 inhibition in the amygdala potentiates the
discriminative stimulus effects of a low alcohol dose (0.5 g/kg, IG)
(A) In the same rats, amygdala infusion of U0126 30 min prior to alcohol (0.5 g/kg, IG;
n=9) potentiated the discriminative stimulus effects of alcohol, without altering response
rate. (B) In contrast, intra-accumbens infusion of U0126 did not alter the discriminative
stimulus effects of the low alcohol dose (0.5 g/kg, IG; n=9), but significantly reduced
response rate, indicating differential involvement of the two brain regions in regulating the
discriminative stimulus effects of alcohol. To evaluate whether MEK/ERK1/2 inhibition
alone produced alcohol-like discriminative stimulus effects, the rats were administered
U0126 30 min prior to water (IG). (C) Intra-amygdala U0126 did not produce alcohol-like
effects (i.e., low alcohol-appropriate responses) and did not alter response rate. (D)
Similarly, intra-accumbens U0126 did not produce alcohol-like effects, but significantly
reduced response rate. Horizontal dashed lines (>80%) denote full substitution for the
discriminative stimulus effects of alcohol. Graphed values are expressed as mean ± s.e.m.
*p<0.05 vs. vehicle (paired t-test).
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Figure 5. Confirmation of decreased pERK1/2 IR following U0126 administration
Following the completion of testing, rats received a unilateral infusion of vehicle and U0126
and were sacrificed 30 min later. (A) Intra-amygdala U0126 (3 μg; n=4) significantly
reduced pERK1/2 IR in the CeA. Representative photomicrographs (20X) showing
decreased pERK1/2 IR following U0126 administration in the CeA. Pictures (central portion
of the CeA) are taken proximal to the injector tracts to avoid artifacts associated with tissue
penetration from the microinjections. (B) Similarly, intra-accumbens U0126 (3 μg; n=5)
administration significantly reduced pERK1/2 in the core. (D) Representative
photomicrographs (20X) showing decreased pERK1/2 IR following U0126 administration in
the nucleus accumbens core (medial to the anterior commissure). Scale bars, 100 μm.
Pictures are taken proximal to the injector tracts to avoid artifacts associated with tissue
damage from the microinjections.
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